Cover Image
Market Research Report

Global Molecular Diagnostics Market (by Application, Technology, End-Use & Region): Insights & Forecast with Potential Impact of COVID-19 (2020-2024)

Published by Koncept Analytics Product code 941645
Published Content info 121 Pages
Delivery time: 1-2 business days
Price
Back to Top
Global Molecular Diagnostics Market (by Application, Technology, End-Use & Region): Insights & Forecast with Potential Impact of COVID-19 (2020-2024)
Published: June 11, 2020 Content info: 121 Pages
Description

The global molecular diagnostics market is estimated to reach US$17.96 billion in 2024, growing at a CAGR of 6.16% for the period spanning from 2020 to 2024. The factors such as rising emergence of infectious diseases rise in global ageing population, increasing incidence of cancer cases are expected to drive the market. However, growth of the industry will be challenged by high initial cost, dearth of trained professionals, urgent need for proper infrastructure and delay in the approval of new molecular diagnostic tests. A few notable trends include progressing sample-to-answer molecular diagnostics market, growth in point of care diagnostics (poct), booming medical devices industry, innovation and technical developments, emergence of liquid biopsy solutions, targeting anti-biotic resistance , decentralization of diagnostic testing, advances in genomics and proteomics.

The global molecular diagnostics market is segmented into, infectious diseases, oncology, genetics, blood screening, and tissue typing.

The global molecular diagnostics market is expected to grow in future mainly due to diagnosis of infectious diseases. In terms of geographical areas, North America is the major contributors to the global molecular diagnostics market supported by rising spread of infectious diseases and presence of a well-established diagnostic infrastructure, technological advancements. Asia Pacific represents the fastest growing market for molecular diagnostics with rapidly developing infrastructure and increasing investments in research and development.

Scope of the report:

The report provides a comprehensive analysis of the global molecular diagnostics market, segmented into, infectious diseases, oncology, genetics, blood screening, and tissue typing.

The major regional markets (North America, Western Europe and Asia Pacific) have been analyzed.

The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.

The competitive landscape of the market, along with the company profiles of leading players (Roche Holding AG, Abbott Laboratories, Danaher Corporation, Hologic Inc. , Biomerieux SA and Thermo Fisher Scientific Inc. ) are also presented in detail.

Key Target Audience:

  • Diagnostics Product Manufacturers
  • End Users
  • Consulting Firms
  • Investment Banks
  • Government Bodies & Regulating Authorities
Table of Contents

Table of Contents

1. Overview

  • 1.1. Diagnostics
  • 1.2. Molecular Diagnostics
  • 1.3. Purpose of Molecular Diagnostics

2. Molecular Diagnostics in COVID-19 Testing

  • 2.1. COVID-19 Diagnostics
  • 2.2. Molecular Diagnostics for COVID-19
  • 2.3. Molecular Diagnostics Test Vendors
  • 2.4. COVID-19 Test in Development
  • 2.5. COVID-19 Molecular Diagnostics Test Kit Production Capacity

3. Global Molecular Diagnostics Market

  • 3.1. Global Molecular Diagnostics Market by Value
  • 3.2. Global Molecular Diagnostics Market Forecast by Value
  • 3.3. Global Molecular Diagnostics Market by Application
    • 3.3.1. Global Infectious Disease Testing Market by Value
    • 3.3.2. Global Infectious Disease Testing Market Forecast by Value
    • 3.3.3. Global Infectious Disease Testing Market Value by Type
    • 3.3.4. Global CT/NG Market by Value & Volume
    • 3.3.5. Global CT/NG Market Forecast by Value & Volume
    • 3.3.6. Global HPV Testing Market by Value & Volume
    • 3.3.7. Global HPV Testing Market Forecast by Value & Volume
    • 3.3.8. Global Oncology Testing Market by Value
    • 3.3.9. Global Oncology Testing Market Forecast by Value
    • 3.3.10. Global Blood Screening Testing Market by Value
    • 3.3.11. Global Blood Screening Testing Market Forecast by Value
    • 3.3.12. Global Genetic Testing Market by Value
    • 3.3.13. Global Genetic Testing Market Forecast by Value
  • 3.4. Global Molecular Diagnostics Market by Technology
    • 3.4.1. Global PCR Testing Market by Value
    • 3.4.2. Global PCR Testing Market Forecast by Value
  • 3.5. Global Molecular Diagnostics Market by End Use
    • 3.5.1. Global Hospitals & Clinics Testing Market by Value
    • 3.5.2. Global Hospitals & Clinics Testing Market Forecast by Value
    • 3.5.3. Global Diagnostics Laboratories Testing Market by Value
    • 3.5.4. Global Diagnostics Laboratories Testing Market Forecast by Value
  • 3.6. Global Molecular Diagnostics Market by Region

4. Regional Market Analysis

  • 4.1. North America
    • 4.1.1. North America Molecular Diagnostics Market by Value
    • 4.1.2. North America Molecular Diagnostics Market Forecast by Value
    • 4.1.3. North America Molecular Diagnostics Market by Application
    • 4.1.4. The U.S. Molecular Diagnostics Market by Value
    • 4.1.5. The U.S. Molecular Diagnostics Market Forecast by Value
  • 4.2. Western Europe
    • 4.2.1. Western Europe Molecular Diagnostics Market by Value
    • 4.2.2. Western Europe Molecular Diagnostics Market Forecast by Value
    • 4.2.3. Western Europe Molecular Diagnostics Market by Application
  • 4.3. Asia Pacific
    • 4.3.1. Asia Pacific Molecular Diagnostics Market by Value
    • 4.3.2. Asia Pacific Molecular Diagnostics Market Forecast by Value
    • 4.3.3. Asia Pacific Molecular Diagnostics Market by Application

5. Market Dynamics

  • 5.1. Growth Drivers
    • 5.1.1. Rising Emergence of Infectious Diseases
    • 5.1.2. Rise in Global Ageing Population
    • 5.1.3. Increasing Incidence of Cancer Cases
  • 5.2. Key Trends and Developments
    • 5.2.1. Progressing Sample-to-Answer Molecular Diagnostics Market
    • 5.2.2. Growth in Point of Care Diagnostics (POCT)
    • 5.2.3. Booming Medical Devices Industry
    • 5.2.4. Innovation and Technical Developments
    • 5.2.5. Emergence of Liquid Biopsy Solutions
    • 5.2.6. Targeting Anti-Biotic Resistance
    • 5.2.7. Decentralization of Diagnostic Testing
    • 5.2.8. Advances in Genomics and Proteomics
  • 5.3. Challenges
    • 5.3.1. High Initial Cost
    • 5.3.2. Dearth of Trained Professionals
    • 5.3.3. Urgent Need for Proper Infrastructure
    • 5.3.4. Delay in the Approval of New Molecular Diagnostic Tests

6. Competitive Landscape

  • 6.1. Global IVD Market
    • 6.1.1. Global IVD Kit Market Share by Company
  • 6.2. Global Molecular Diagnostics Market
    • 6.2.1. Global Molecular Diagnostics Market Share by Company
    • 6.2.2. Global Infectious Disease Testing Market Share by Company
    • 6.2.3. Global Blood Screening Testing Market Share by Company
    • 6.2.4. Revenue and Market Cap Comparison

7. Company Profiles

  • 7.1. Roche Holding AG
    • 7.1.1. Business Overview
    • 7.1.2. Financial Overview
    • 7.1.3. Business Strategies
  • 7.2. Abbott Laboratories
    • 7.2.1. Business Overview
    • 7.2.2. Financial Overview
    • 7.2.3. Business Strategies
  • 7.3. Danaher Corporation
    • 7.3.1. Business Overview
    • 7.3.2. Financial Overview
    • 7.3.3. Business Strategies
  • 7.4. Hologic Inc.
    • 7.4.1. Business Overview
    • 7.4.2. Financial Overview
    • 7.4.3. Business Strategies
  • 7.5. Biomerieux SA
    • 7.5.1. Business Overview
    • 7.5.2. Financial Overview
    • 7.5.3. Business Strategies
  • 7.6. Thermo Fisher Scientific Inc.
    • 7.6.1. Business Overview
    • 7.6.2. Financial Overview
    • 7.6.3. Business Strategies

List of Figures

  • IVD Market - Segments by Technology
  • Molecular Diagnostcs - Traditional Process
  • Molecular Diagnostics Breakdown
  • Main Purposes of Molecular Diagnostics
  • COVID-19 Spread
  • COVID-19 Diagnostics Testing
  • Working of Molecular Diagnostics Testing
  • Global Molecular Diagnostics Market by Value (2015-2019)
  • Global Molecular Diagnostics Market Forecast by Value (2020-2024)
  • Global Molecular Diagnostics Market by Application (2019)
  • Global Infectious Disease Testing Market by Value (2015-2019)
  • Global Infectious Disease Testing Market Forecast by Value (2020-2024)
  • Global Infectious Disease Testing Market Value by Type (2019)
  • Global CT/NG Market by Value & Volume (2015-2019)
  • Global CT/NG Market Forecast by Value & Volume (2020-2024)
  • Global HPV Market by Value & Volume (2015-2019)
  • Global HPV Market Forecast by Value & Volume (2020-2024)
  • Global Oncology Testing Market by Value (2015-2019)
  • Global Oncology Testing Market Forecast by Value (2020-2024)
  • Global Blood Screening Testing Market by Value (2015-2019)
  • Global Blood Screening Testing Market Forecast by Value (2020-2024)
  • Global Genetic Testing Market by Value (2015-2019)
  • Global Genetic Testing Market Forecast by Value (2020-2024)
  • Global Molecular Diagnostics Market by Technology (2019)
  • Global PCR Testing Market by Value (2015-2019)
  • Global PCR Testing Market Forecast by Value (2020-2024)
  • Global Molecular Diagnostics Market by End Use (2019)
  • Global Hospitals & Clinics Testing Market by Value (2015-2019)
  • Global Hospitals & Clinics Testing Market Forecast by Value (2020-2024)
  • Global Diagnostics Laboratories Testing Market by Value (2015-2019)
  • Global Diagnostics Laboratories Testing Market Forecast by Value (2020-2024)
  • Global Molecular Diagnostics Market by Region (2019)
  • North America Molecular Diagnostics Market by Value (2015-2019)
  • North America Molecular Diagnostics Market Forecast by Value (2020-2024)
  • North America Molecular Diagnostics Market by Application (2019)
  • The U.S. Molecular Diagnostics Market by Value (2015-2019)
  • The U.S. Molecular Diagnostics Market Forecast by Value (2020-2024)
  • Western Europe Molecular Diagnostics Market by Value (2015-2019)
  • Western Europe Molecular Diagnostics Market Forecast by Value (2020-2024)
  • Western Europe Molecular Diagnostics Market by Application (2019)
  • Asia Pacific Molecular Diagnostics Market by Value (2015-2019)
  • Asia Pacific Molecular Diagnostics Market Forecast by Value (2020-2024)
  • Asia Pacific Molecular Diagnostics Market by Application (2019)
  • Worldwide Ageing Population 60 Years or Older (2015-2019)
  • Global Cancer Prevalence (2019-2024)
  • Global Sample-to-Answer Molecular Diagnostics Market Value (2015-2019)
  • Global POCT Device Sales (2015-2019)
  • Global Medical Equipment/Devices Sales (2019-2024)
  • Global IVD Kit Market Share by Company (2019)
  • Global Molecular Diagnostics Market Share by Company (2019)
  • Global Infectious Disease Testing Market Share by Company (2019)
  • Global Blood Screening Testing Market Share by Company (2019)
  • Roche Holding AG Sales by Segments (2019)
  • Roche Holding AG Sales by Geography (2019)
  • Roche Holding AG Sales and Net Income (2015-2019)
  • Abbott Laboratories Net Sales by Segment (2019)
  • Abbott Laboratories Net Sales by Region (2019)
  • Abbott Laboratories Net Sales and Net Earnings (2015-2019)
  • Danaher Corporation Sales by Segment (2019)
  • Danaher Corporation Sales by Geography Regions (2019)
  • Danaher Corporation Sales and Net Earnings (2015-2019)
  • Hologic Inc. Revenue by Segments (2019)
  • Hologic Inc. Revenue by Region (2019)
  • Hologic Inc. Revenue and Net Income (Loss) (2015-2019)
  • Biomerieux SA Sales by Segments (2019)
  • Biomerieux SA Sales by Region (2019)
  • Biomerieux SA Revenue and Net Income (2015-2019)
  • Thermo Fisher Scientific Inc. Revenue by Segments (2019)
  • Thermo Fisher Scientific Inc. Sales by Region (2019)
  • Thermo Fisher Scientific Inc. Health, Inc. Revenue and Net Income (2015-2019)

List of Tables

  • Selected Molecular Diagnostics Test Vendors (2020)
  • COVID-19 Test Launched/In Development (2020)
  • COVID-19 Moldx Test Kit Production Capacity (2020)
  • Growing Cases and Prevalence of STDs in the US (2011-2018)
  • Key Players - Revenue & Market Cap Comparison (2019)
Back to Top